Product Information
HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET is a generic product labeled by SpecGx LLC, priced at $0.1354 per EA under NDC 00406012423. Its NADAC has been published 555 times since Feb 17, 2016.
FDA first approved this application on Sep 8, 2000. Its Orange Book therapeutic-equivalence code is AA.
Strength
325; 7.5 mg/1; mg/1
Manufacturer
SpecGx LLCNDC
00406012423
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ACETAMINOPHEN; HYDROCODONE BITARTRATEApproval Type
Generic (ANDA)
FDA Application
ANDA040405FDA Approved
9/8/2000
TE Code
AA
On Market Since
9/8/2000
Pharmacological Classes
Price Statistics
The NADAC for HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET has been published 555 times since Feb 17, 2016, and over the history we have for it it has declined 35.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1354 per EA |
|---|---|
| All-time high | $0.2135 (Apr 13, 2016) |
| All-time low | $0.0932 (Dec 18, 2019) |
| 52-week high | $0.1522 |
| 52-week low | $0.1354 |
| Median price | $0.1371 |
| Average price | $0.1408 |
| Largest weekly change | +41.5% (Jan 22, 2020) |
| Weeks tracked | 555 |
| Tracking since | Feb 17, 2016 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
SpecGx LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
HYDROCODONE BITARTRATE AND ACETAMINOPHEN market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Opioid Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET, manufactured by SpecGx LLC, is $0.1354 per EA (NDC 00406012423), effective Sep 30, 2026.
How has the price of HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET changed over time?
Over the history we have for it, the NADAC for HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET has declined 35.2%. It has been tracked across 555 weekly CMS publications since Feb 17, 2016.
What are the highest and lowest recorded NADAC prices for HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET?
Since Feb 17, 2016, the NADAC for HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET has ranged from a low of $0.0932 (Dec 18, 2019) to a high of $0.2135 (Apr 13, 2016), with a median of $0.1371 per EA.
Are there cheaper alternatives to HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET?
HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET (NDC 00406012423) is labeled by SpecGx LLC, and CMS classifies it as a generic product.